The WHO recommends CrAg screening in HIV-infected patients with a low CD4 T-cell count (<100 cells/μL) prior to ART initiation to prevent CM development and cryptococcal infections associated with immune reconstitution inflammatory syndrome [51]. This evidence concerns the gene CD4 and cryptococcosis.